To investigate whether high frequency airflow oscillation (HFAO), delivered using Aerosure, increases six minute walk distance (6MWD) and reduces exertional breathlessness in patients with severe chronic obstructive pulmonary disease (COPD).
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
42
Active Aerosure device
Device designed to appear identical to active device but with HFAO mechanism disabled
King's College Hospital, Bessemer Road, Denmark Hill
London, United Kingdom
Six minute walk distance (6MWD)
Time frame: up to 6 minutes
end-6MWD Borg breathlessness
Time frame: after 6 minute walk test
Arterial oxygen saturation (SpO2)
Time frame: At start of 6 minute walk test and after every 1 minute
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.